Find uplifting stories about heroes, innovations, and solutions
26 results for "sickle cell disease"
A discovery about baby blood just transformed life for sickle cell patients forever. Two researchers won the "Oscars of Science" for finding the switch that could cure a painful disease affecting millions.
Scientists are calling new gene editing treatments a potential "functional cure" for sickle cell disease, offering hope to millions. Early results show patients living pain-free after a single treatment.
A breakthrough gene editing treatment has achieved what doctors call a "functional cure" for sickle cell disease, with 27 out of 28 patients experiencing zero painful crises after receiving the therapy. The one-time treatment edits patients' own blood cells to correct the genetic mutation, offering new hope for 100,000 Americans living with this painful disease.
A single gene-editing treatment has freed nearly all trial patients from the crushing pain crises that define sickle cell disease. Doctors are calling it a functional cure that uses patients' own cells to rewrite their future.
A groundbreaking gene therapy trial has achieved what doctors call a "functional cure" for sickle cell disease, eliminating painful crises in 27 out of 28 patients. The one-time treatment uses gene editing to fix the blood disorder that has killed patients decades too soon.
Twenty-seven out of 28 patients with severe sickle cell disease are now living pain-free after a groundbreaking gene editing treatment. The one-time therapy is offering new hope to people living with a genetic disorder that typically shortens life expectancy to the mid-40s.
A New Jersey teen became the first patient in the state to be cured of sickle cell disease using his own genetically modified cells, eliminating the need for a donor. The breakthrough offers hope to thousands who lack family matches.
Nigerian artist Adekunle Gold's foundation just delivered life-changing medical support to over 400 people living with sickle cell disease. The initiative included everything from specialist care to three months of free medication.
A 24-year-old who lost his sister to sickle cell disease just became the first Michigan patient cured by groundbreaking gene therapy. Chantez Sanford is heading back to college healthier than he's ever been.
Uganda is raising $4 million to complete East Africa's second bone marrow transplant facility, bringing life-saving treatment home for thousands of patients who previously had to travel abroad. Pearl Bank, Rotary Uganda, and the Joint Clinical Research Centre are leading the campaign to finish the groundbreaking medical center in Lubowa.
Daniel Cressy became the first person in his region to receive groundbreaking gene therapy that cured his sickle cell disease. Now he's pursuing his lifelong dream of becoming a licensed pilot.
A Louisiana man with lifelong sickle cell disease received groundbreaking gene therapy that eliminated his symptoms and opened the door to his dream career as a pilot. His story represents hope for thousands living with this painful genetic condition.
Nemours Children's Hospital in Wilmington can now offer a groundbreaking one-time gene therapy that could give children with sickle cell disease a chance at a transformed life. The FDA-approved treatment addresses the root genetic cause of the disease that affects 100,000 Americans and shortens life expectancy by more than 20 years.
Uganda is raising $4 million to build its first bone marrow transplant center, offering hope to 20,000 children born annually with sickle cell disease. The facility could cure patients who currently face $300,000-500,000 treatment costs abroad.
Children with sickle cell disease now have a survival rate exceeding 95% thanks to breakthrough stem cell transplant techniques. New treatments are also opening curative options for kids who previously had no donor matches.
Austin Louis spent his entire life in excruciating pain from sickle cell disease until a revolutionary gene therapy treatment made him feel like "a new human." The 20-year-old New Jersey man became the first patient at Children's Hospital of Philadelphia to receive the FDA-approved CRISPR treatment outside clinical trials.
A Ugandan biotech firm just received a U.S. patent for a gene therapy that could treat sickle cell disease for 95% less than current cures. The breakthrough could finally bring life-saving treatment to 20 million patients worldwide who can't afford existing options.
After decades of research, gene therapy is bringing lasting relief to sickle cell patients after just one treatment. UCLA researchers are leading the charge to cure a disease that affects 100,000 Americans.
After becoming the first country to approve a revolutionary gene-editing therapy in 2023, the UK is now using Casgevy to treat patients with sickle cell disease and β-thalassaemia. The treatment has shown remarkable results, freeing 97% of sickle cell patients from painful episodes for over a year.
Victoria Hospital in Kisumu has become Kenya's first public facility to offer automated red blood cell exchange therapy for sickle cell patients. The specialized machine offers hope to thousands in western Kenya, where the disease is highly prevalent.
Showing 20 of 26